HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia.

Tersigni C., Redman CW., Dragovic R., Tannetta D., Scambia G., Di Simone N., Sargent I., Vatish M.

In normal pregnancy, villous cytotrophoblast and syncytiotrophoblast do not express HLA Class I and Class II molecules, while invasive extravillous trophoblast only express class I HLA-C and the atypical class Ib antigens, HLA-G, -E and -F. Inadequate maternal tolerance of invasive trophoblast has been proposed as a possible immunologic trigger of poor trophoblast invasion and subsequent occurrence of pre-eclampsia. This study aimed to investigate possible aberrant expression of class II HLA-DR on placentae and syncytiotrophoblast-derived extracellular vesicles (STEVs), obtained by dual placental perfusion, from pre-eclampsia (n = 23) and normal pregnant (n = 14) women. Here we demonstrate that HLA-DR can be detected in syncytiotrophoblast from a significant proportion of pre-eclampsia but not control placentae. HLA-DR was also observed, by flow cytometry, on STEVs and associated with placental alkaline phosphatase to validate their placental origin. HLA-DR positive syncytiotrophoblast was detected in placental biopsies from pre-eclampsia but not normal control cases, using immunohistochemistry. The HLA may be fetal or maternal origin. In the latter case a possible mechanism of acquisition is trogocytosis.

DOI

10.1016/j.jri.2018.06.024

Type

Journal article

Publication Date

2018-09-01T00:00:00+00:00

Volume

129

Pages

48 - 52

Total pages

4

Keywords

Extracellular vesicles, Feto-maternal interface, HLA-DR, Pre-eclampsia, Syncytiotrophoblast, Adult, Extracellular Vesicles, Female, Fetus, Flow Cytometry, Gene Expression Regulation, HLA-DR Antigens, Humans, Immune Tolerance, Immunohistochemistry, Maternal-Fetal Exchange, Placenta, Pre-Eclampsia, Pregnancy, Trophoblasts

Permalink More information Close